✉news BusinessStartups first seen 20 h ago, last 16 h ago, peak #11
ADARx raises $446.3 million in IPO
Original: ADARx bags $446.3M IPO as another siRNA startup readies for its debut
RNA-focused biotech ADARx has priced an initial public offering raising $446.3 million, a strong showing for a genetic-medicine startup. The listing comes as another siRNA company prepares its own stock market debut, signalling renewed investor appetite for RNA interference platforms after a lean stretch for biotech offerings.
Why now: Investors are tracking a wave of siRNA startup listings as biotech IPO activity picks up.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/2641